-
1.发明公开6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-[(2-FURANYLCARBOXYL)OXY]-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT 有权6.ALPHA，9.ALPHA.二氟17.ALPHA .-（2- FURANYLCARBOXYL）OXY-11.BETA.羟基16.ALPHA.甲基-3-氧代雄甾-1,4-二烯 17硫代羧酸S-氟甲基酯作为抗炎药
公开(公告)号：EP1305329A1
公开(公告)日：2003-05-02
申请号：EP01953272.0
申请日：2001-08-03
申请人： GLAXO GROUP LIMITED
CPC分类号： C07J31/006
摘要： According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
-
2.发明授权6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT 有权6.ALPHA，9.ALPHA.二氟17.ALPHA .-（2- FURANYLCARBOXYL）OXY-11.BETA.羟基16.ALPHA.甲基-3-氧代雄甾-1,4-二烯 17硫代羧酸S-氟甲基酯作为抗炎药
公开(公告)号：EP1305329B2
公开(公告)日：2015-03-18
申请号：EP01953272.0
申请日：2001-08-03
申请人： GLAXO GROUP LIMITED
CPC分类号： C07J31/006
-
公开(公告)号：EP3510994A1
公开(公告)日：2019-07-17
申请号：EP18193195.7
申请日：2003-02-04
申请人： GLAXO GROUP LIMITED
发明人： BIGGADIKE, Keith , BUXTON, Ian , COOTE, Steven, John , NICE, Rosalyn, Kay , REED, Kenton, Lewis , SAYANI, Amyn , SHARMA, Avinash, Chander
摘要： There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)
or a solvate thereof.-
公开(公告)号：EP1478340B1
公开(公告)日：2018-09-12
申请号：EP03737365.1
申请日：2003-02-04
申请人： Glaxo Group Limited
发明人： BIGGADIKE, Keith , BUXTON, Ian , COOTE, Steven, John , NICE, Rosalyn, Kay , REED, Kenton, Lewis , SAYANI, Amyn , SHARMA, Avinash, Chander
CPC分类号： A61K9/0078 , A61K9/0043 , A61K31/56 , A61K31/58 , A61K47/38
摘要： There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)or a solvate thereof.
-
5.发明授权6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT 有权6.ALPHA，9.ALPHA.二氟17.ALPHA .-（2- FURANYLCARBOXYL）OXY-11.BETA.羟基16.ALPHA.甲基-3-氧代 - 雄甾-1,4-二烯 17-碳酸S-氟代乙酸酯ALSENTZÜNDUNGSHEMMENDESARZNEIMITTEL
公开(公告)号：EP1305329B1
公开(公告)日：2007-12-05
申请号：EP01953272.0
申请日：2001-08-03
申请人： GLAXO GROUP LIMITED
CPC分类号： C07J31/006
摘要： According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
-
6.发明公开PHARMACEUTICAL FORMULATION COMPRISING AN AQUEOUS SUSPENSION OF AN ANDROSTANE DERIVATIVE FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC CONDITIONS 有权随着对炎性和过敏性疾病的治疗中具有雄甾烷衍生物的含水悬浮液的药物制剂
公开(公告)号：EP1478340A1
公开(公告)日：2004-11-24
申请号：EP03737365.1
申请日：2003-02-04
申请人： GLAXO GROUP LIMITED
发明人： BIGGADIKE, Keith , BUXTON, Ian , COOTE, Steven, John , NICE, Rosalyn, Kay , REED, Kenton, Lewis , SAYANI, Amyn , SHARMA, Avinash, Chander
CPC分类号： A61K9/0078 , A61K9/0043 , A61K31/56 , A61K31/58 , A61K47/38
摘要： There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)or a solvate thereof.
摘要翻译： 本发明提供一种药物制剂，包含式（I）的微粒化合物或它们的溶剂合物的wässrige悬浮液。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.012 秒)
